GTR 99944083
Bids Are Invited For It Is The Object Of Trading Selection Of Specialized Company To Form The Price Registration System For Any Acquisition Of Medicines, To Meet The Municipal Health Network, Under The Responsibility Of The Municipal Health Secretariat Of Ivinhema, According To Quantities, Conditions And Other Specifications Contained In The Notice, Its Annexes And The Term Of Reference
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
99944083
Tendering Authority
Subscribe to view
Tender No
031/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For It Is The Object Of Trading Selection Of Specialized Company To Form The Price Registration System For Any Acquisition Of Medicines, To Meet The Municipal Health Network, Under The Responsibility Of The Municipal Health Secretariat Of Ivinhema, According To Quantities, Conditions And Other Specifications Contained In The Notice, Its Annexes And The Term Of Reference
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
11-08-2025
Closed
Work Detail
Ascorbic Acid, Dosage/Concentration: 100 Mg/Ml, Type Use: Injectable, Ampoule 5, 00 Ml, Acetylcysteine, Dosage/Concentration: 600 Mg, Indication: Powder For Oral Solution, Envelope, Dosage/Concentration: 40 Mg/Ml, Pharmaceutical Form: Syrup, Bottle 100, 20 Mg/Ml, Indication: Syrup, Dosage/Concentration: 200 Mg/Ml, Type Use: Oral Solution, Bottle 30, 22/07/2025, 28/07/2025, Calcium Folic, Dosage/Concentration: 15 Mg, Compressed, Valproic Acid, Dosage/Concentration: 300 Mg, Indication: Enteric Release, Acretine, Dosage/Concentration, 10 Mg, Distilled Water, Distilled Water Physical Aspect: Sterile And Apirogenic, Packaging Type: In Closed System, 1000 Bag, Adalimmab, Dosage/Concentration: 40 Mg, Injectable Solution, Syringe, Alteplase, Dosage/Concentration: 50 Mg, Liophile Powder For Diluent, Vial, Alfaepoetin, Dosage/Concentration: 4,000 Iu/Ml, Pharmaceutical Form: Solution Injectable, Alprazolam, Dosage/Concentration: 0, 50 Mg, Additional: Slow Release, Dosage/Concentration: 2 Mg, Amiodarone, Dosage/Concentration: 50Mg/Ml, Indication: Injectable, Ampoule 3, Amoxicillin, Dosage/Concentration: 500Mg + 125Mg, Active Ingredient: Associated With Potassium Clavulanate, Bottle 75, Amantadine, Dosage/Concentration: 100 Mg, Atropin, 50 Mg/Ml, Use: Injectable Solution, Ampoule 1, 25 Mg/Ml, Dye, Type: Methylene Blue, Physical Appearance: Ci 52015, Bottle 60, Testosterone, Composition: Salt Undecilty, Dosage/Concentration: 250 Mg/Ml, Ampoule 4 Hydrochloride, Dvegea, Benzilpernicillin, Usage: Injectable, Dosage/Concentration: 1.200.000Ui, Presentation: Benzatin, Dosage/Concentration: 600.000Ui, Dosage/Concentration: 5.000Ui, Presentation: Potassa, Beclomethasone Dipropionate, Dosage/Concentration: 400 Mcg, Flacone 2, Bimatoprost, Composition: Associated With Timolol Maleato, 3 Mg + 5 Mg/Ml, Ophthalmic Solution, Vial 5, Brimonidine Tartarate, Dosage/Concentration: 2 Mg/Ml, Presentation: Eye Drops, Vial 10, Brinzolamide, Dosage/Concentration: 10 Mg/Ml, Pharmaceutical Form: Ophthalmic Suspension, Bromexine, Oral Solution - Gouts 50, Bupivacaine Hydrochloride, 5% + 1/200.000Ui, Presentation: Associated With Epinephrine, Type: Injectable Solution, Bottle 20, Phenoterol Bromidrate, Dosage/Concentration: 5 Mg/Ml, Pharmaceutical Form: Oral Solution, Scopolamine, Indication: Injectable, Candesartan, Composition: Associated With Felodipine, Dosage/Concentration: 16Mg + 2, 5 Mg, Dosage/Concentration: 16Mg + 5 Mg, Dosage/Concentration: 16Mg + 12, 5Mg, Presentation: Associated With Hydrochlorothiazide, Dosage/Concentration: 8Mg + 12, Carbamazepine, Dosage/Concentration: 400 Mg, Presentation: Controlled Release, Calcium Carbonate, Composition: Associated With Vitamin D3, Dosage/Concentration: Dosage/Concentration: 500 Mg + 400 Iu, Dosage/Concentration: 500 Mg, Ceftriaxone, Dosage/Concentration: 1 G, Pharmaceutical Form: Powder For Injectable Solution, Celecoxib, Dosage/Concentration: 200 Mg, Ketoprofen, Additional: Retard, Dosage/Concentration: 150 Mg, Pharmaceutical Form: Prolonged Release, Br0393831 Cyclobenzaprine Hydrochloride, Composition: Associated With Slylixinate Lysine, Dosage/Concentration: 5 Mg + 125 Mg, Cilostazole, Cimetidine, Citalopram, Clindamycin, Clobazam, Dosage/Concentration: 20 Mg, Clonidine Hydrochloride, 1 Mg, 15 Mg, 2 Mg, Chloriazoxide, Associated With Amitriptyline, Dosage/Concentration: Concentration: 5Mg + 12, Buspirone Hydrochloride, Dosage/Concentration: 5 Mg, Dimenhydrate, Associated With
Key Value
Tender Value
5,069,290 - BRL
Tender Documents
Global Tender Document
11c12e32-0f44-4c4d-8740-f928235cf340.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.